<?xml version="1.0" encoding="UTF-8"?>
<ack id="ack0010">
 <title>Acknowledgments</title>
 <p>Research in the Dömling laboratory is sponsored through ITN “Accelerated Early stage drug dIScovery” (
  <funding-source id="gs1">AEGIS</funding-source>, grant agreement 675555), the 
  <funding-source id="gs2">
   <institution-wrap>
    <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
    <institution>National Institute of Health</institution>
   </institution-wrap>
  </funding-source> (NIH) (2R01GM097082-05), the 
  <funding-source id="gs3">European Lead Factory</funding-source> (IMI) (grant agreement 115489), the 
  <funding-source id="gs4">Qatar National Research Foundation</funding-source> (NPRP6-065-3-012), 
  <funding-source id="gs5">Cofunds Alert</funding-source> (grant agreement 665250), 
  <funding-source id="gs6">Prominent</funding-source> (grant agreement 754425), and 
  <funding-source id="gs7">KWF Kankerbestrijding grant</funding-source> (grant agreement 10504). L.G. is grateful for a CSC stipendship. Both authors are grateful to Micky Tortorella (GBH) for helpful discussions.
 </p>
 <sec id="sec5">
  <title>Author Contributions</title>
  <p id="p0180">A.D. and L.G. wrote the manuscript.</p>
 </sec>
</ack>
